Continuity Biosciences Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$9.4M
- Investors
-
1
Continuity Biosciences General Information
Description
Developer of advanced drug delivery technologies designed for treating complex diseases. The company develops technologies for cell reprogramming and drug delivery to create combination products that enhance novel therapies using technology portfolios ranging from nanofluidic systems for drug delivery to cell storage systems that enable donor/stem cell transplantation and immune modulation, enabling medical institutions to treat chronic and complex diseases.
Contact Information
Website
www.continuitybiosciences.comCorporate Office
- 111 James Jackson Avenue
- Suite 131
- Cary, NC 27513
- United States
Corporate Office
- 111 James Jackson Avenue
- Suite 131
- Cary, NC 27513
- United States
Continuity Biosciences Timeline
Continuity Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 19-Aug-2025 | $9.4M | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 21-Feb-2025 | Completed | Generating Revenue | |||
| 1. Seed Round | 02-Jul-2024 | $2.45M | $2.45M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Continuity Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Continuity Biosciences Patents
Continuity Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260216505-A1 | System and method for delivery of nucleic acid molecules by iontophoresis | Pending | 24-Jan-2025 | ||
| WO-2026161809-A1 | System and method for delivery of nucleic acid molecules by iontophoresis | Pending | 24-Jan-2025 | ||
| US-20260083966-A1 | Reservoir for use with a medical device and system for interventional drug delivery | Pending | 25-Sep-2024 | ||
| WO-2026072722-A1 | Reservoir for use with a medical device and system for interventional drug delivery | Pending | 25-Sep-2024 | ||
| AU-2025224299-A1 | Delivery of chemotherapy drug via an implantable iontophoresis drug delivery device | Pending | 23-Feb-2024 | A61K31/555 |
Continuity Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Continuity Biosciences Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| I3P | Accelerator/Incubator |
Continuity Biosciences Investments & Acquisitions (2)
Continuity Biosciences’s most recent deal was a Merger/Acquisition with Focal Medical (Drug Delivery). The deal was made on 04-Jun-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Focal Medical (Drug Delivery) | 04-Jun-2025 | Merger/Acquisition | Drug Delivery | ||
| PinPrint | 29-Apr-2025 | Early Stage VC | Drug Delivery |
Continuity Biosciences Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Focal Medical (Drug Delivery) | Cary, NC | 2014 |
Continuity Biosciences FAQs
-
When was Continuity Biosciences founded?
Continuity Biosciences was founded in 2024.
-
Where is Continuity Biosciences headquartered?
Continuity Biosciences is headquartered in Cary, NC.
-
What is the size of Continuity Biosciences?
Continuity Biosciences has 27 total employees.
-
What industry is Continuity Biosciences in?
Continuity Biosciences’s primary industry is Drug Delivery.
-
Is Continuity Biosciences a private or public company?
Continuity Biosciences is a Private company.
-
What is Continuity Biosciences’s current revenue?
The current revenue for Continuity Biosciences is .
-
How much funding has Continuity Biosciences raised over time?
Continuity Biosciences has raised $11.9M.
-
Who are Continuity Biosciences’s investors?
I3P has invested in Continuity Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
